Analysen von Dani Saurymper
13.02.15 | GSK overweight | Barclays Capital | |
10.02.15 | AstraZeneca verkaufen | Barclays Capital | |
17.11.14 | AstraZeneca neutral | Barclays Capital |
13.02.15 | GSK overweight | Barclays Capital | |
10.02.15 | AstraZeneca verkaufen | Barclays Capital | |
17.11.14 | AstraZeneca neutral | Barclays Capital |